Topical IL-1-Ra for Treatment of Posterior Blepharitis
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness and safety of Topical
Interleukin-1-Receptor Antagonist in treatment of signs and symptoms of posterior
blepharitis.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Massachusetts Eye and Ear Infirmary Reza Dana, MD
Treatments:
Interleukin 1 Receptor Antagonist Protein Lubricant Eye Drops